Rockefeller Capital Management L.P. Biogen Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $643,259 - $743,306	-2,337 Reduced 22.57%	8,019 $2.28 Million
Q1 2023 May 17, 2023	BUY	$256.56 - $292.34 $998,274 - $1.14 Million	3,891 Added 60.19%	10,356 $2.88 Million
Q4 2022 Mar 06, 2023	BUY	$252.44 - $306.72 $75,732 - $92,016	300 Added 4.87%	6,465 $1.79 Million
Q3 2022 Nov 02, 2022	SELL	$194.69 - $268.46 $37,380 - $51,544	-192 Reduced 3.02%	6,165 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $33,194 - $39,474	-177 Reduced 2.71%	6,357 $1.3 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $64,525 - $81,298	333 Added 5.37%	6,534 $1.38 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $1.62 Million - $2.08 Million	-7,219 Reduced 53.79%	6,201 $1.49 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $608,711 - $793,826	-2,151 Reduced 13.81%	13,420 $3.8 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $865,060 - $1.39 Million	-3,340 Reduced 17.66%	15,571 $5.39 Million
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $957,708 - $1.12 Million	3,942 Added 26.33%	18,911 $5.29 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $1.88 Million - $2.84 Million	-7,974 Reduced 34.76%	14,969 $3.66 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $270,594 - $312,435	-1,022 Reduced 4.26%	22,943 $6.51 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $139,417 - $184,634	-539 Reduced 2.2%	23,965 $6.41 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $2.19 Million - $2.78 Million	8,139 Added 49.73%	24,504 $7.75 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $922,491 - $1.27 Million	-4,192 Reduced 20.39%	16,365 $4.86 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $49.9 Million - $56 Million	-229,540 Reduced 91.78%	20,557 $4.79 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $910,930 - $1 Million	-4,154 Reduced 1.63%	250,097 $58.5 Million
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $15.8 Million - $24.7 Million	-72,747 Reduced 22.25%	254,251 $60.1 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $1.5 Million - $1.9 Million	5,376 Added 1.67%	326,998 $98.4 Million
Q3 2018 Nov 02, 2018	BUY	$293.51 - $383.83 $10.9 Million - $14.2 Million	37,049 Added 13.02%	321,622 $114 Million
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $847,498 - $1.01 Million	-3,291 Reduced 1.14%	284,573 $82.6 Million
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $74.9 Million - $106 Million	287,864 New	287,864 $78.8 Million

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account